ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Exor NV

Exor NV (EYX)

88.70
0.45
(0.51%)
Closed December 23 4:00PM
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
88.70
Bid
88.55
Ask
88.85
Volume
213
88.05 Day's Range 88.75
85.92 52 Week Range 106.10
Market Cap
Previous Close
88.25
Open
88.05
Last Trade
10
@
88.75
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
618
Shares Outstanding
220,984,247
Dividend Yield
0.52%
PE Ratio
4.65
Earnings Per Share (EPS)
18.98
Revenue
43.76B
Net Profit
4.19B

About Exor NV

Sector
Offices-holdng Companies,nec
Industry
Offices-holdng Companies,nec
Website
Headquarters
Amsterdam, North Holland, Nld
Founded
-
Exor NV is listed in the Offices-holdng Companies sector of the Tradegate (DE) with ticker EYX. The last closing price for Exor NV was 88.25 €. Over the last year, Exor NV shares have traded in a share price range of 85.92 € to 106.10 €.

Exor NV currently has 220,984,247 shares outstanding. The market capitalization of Exor NV is 19.50 € billion. Exor NV has a price to earnings ratio (PE ratio) of 4.65.

EYX Latest News

Exor Press Release - Periodic Report on the Buyback Program

Exor Press Release - Periodic Report on the Buyback Program Amsterdam, 11 November 2024 EXOR N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM Exor N.V. (AMS: EXO) (“Exor” or the “Company”) announces...

Exor Press Release - Periodic Report on the Buyback Program

Exor Press Release - Periodic Report on the Buyback Program Amsterdam, 4 November 2024 EXOR N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM Exor N.V. (AMS: EXO) (“Exor” or the “Company”) announces...

Exor Press Release - Periodic Report on the Buyback Program

Exor Press Release - Periodic Report on the Buyback Program Amsterdam, 28 October 2024 EXOR N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM Exor N.V. (AMS: EXO) (“Exor” or the “Company”) announces...

Exor Press Release - Evolution Early-Stage Activities

Exor Press Release - Evolution Early-Stage Activities Amsterdam, 25 October 2024 EXOR ANNOUNCES EVOLUTION OF ITS EARLY-STAGE VENTURE ACTIVITIES Exor announces that Noam Ohana, who has led...

Exor Press Release - Periodic Report on the Buyback Program

Exor Press Release - Periodic Report on the Buyback Program Amsterdam, 21 October 2024 EXOR N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM Exor N.V. (AMS: EXO) (“Exor” or the “Company”) announces...

Exor Press Release - Periodic Report on the Buyback Program

Exor Press Release - Periodic Report on the Buyback Program Amsterdam, 14 October 2024 EXOR N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM Exor N.V. (AMS: EXO) (“Exor” or the “Company”) announces...

Exor Press Release - Periodic Report on the Buyback Program

Exor Press Release - Periodic Report on the Buyback Program Amsterdam, 7 October 2024 EXOR N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM Exor N.V. (AMS: EXO) (“Exor” or the “Company”) announces...

Exor Press Release - Periodic Report on the Buyback Program

Exor Press Release - Periodic Report on the Buyback Program Amsterdam, 30 September 2024 EXOR N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM Exor N.V. (AMS: EXO) (“Exor” or the “Company”...

Exor Press Release - H1 2024 Results

Exor Press Release - H1 2024 Results Amsterdam, 24 September 2024 NAV REACHED €38.3 BILLION AT 30 JUNE 2024, AN INCREASE OF €2.9 BILLION DURING THE FIRST HALF OF 2024 NAV per share increased by 9...

Exor Press Release - Periodic Report on the Buyback Program

Exor Press Release - Periodic Report on the Buyback Program Amsterdam, 23 September 2024 EXOR N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM Exor N.V. (AMS: EXO) (“Exor” or the “Company”...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-4.75-5.0829320492293.4593.6587.0562689.01480831DE
4-6.8-7.1204188481795.596.887.0567393.0440447DE
12-11.05-11.077694235699.75100.987.0561895.35829875DE
26-8.9-9.1188524590297.6101.486.754195.30290466DE
52-2.04-2.2481816178190.74106.185.9252597.38862297DE
15624.2837.690158335964.42106.162.8833893.12558185DE
26024.2837.690158335964.42106.162.8833893.12558185DE

EYX - Frequently Asked Questions (FAQ)

What is the current Exor NV share price?
The current share price of Exor NV is 88.70 €
How many Exor NV shares are in issue?
Exor NV has 220,984,247 shares in issue
What is the market cap of Exor NV?
The market capitalisation of Exor NV is EUR 19.5B
What is the 1 year trading range for Exor NV share price?
Exor NV has traded in the range of 85.92 € to 106.10 € during the past year
What is the PE ratio of Exor NV?
The price to earnings ratio of Exor NV is 4.65
What is the cash to sales ratio of Exor NV?
The cash to sales ratio of Exor NV is 0.45
What is the reporting currency for Exor NV?
Exor NV reports financial results in EUR
What is the latest annual turnover for Exor NV?
The latest annual turnover of Exor NV is EUR 43.76B
What is the latest annual profit for Exor NV?
The latest annual profit of Exor NV is EUR 4.19B
What is the registered address of Exor NV?
The registered address for Exor NV is GUSTAV MAHLERPLEIN 25, AMSTERDAM, NORTH HOLLAND, 1082 MS
What is the Exor NV website address?
The website address for Exor NV is www.exor.com
Which industry sector does Exor NV operate in?
Exor NV operates in the OFFICES-HOLDNG COMPANIES,NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0RARAPT Therapeutics Inc
1.61 €
(101.25%)
83.81k
KASHIntellabridge Technology Corp
0.047 €
(88.00%)
1.24M
4APApollo Minerals Ltd
0.01 €
(66.67%)
30
AWY0Percheron Therapeutics Ltd
0.007 €
(55.56%)
660k
1W81WISeKey International Holding Ltd
9.70 €
(44.78%)
4.81k
WWTWater Ways Technologies Inc
0.0045 €
(-95.91%)
2.53k
L7C2Windfall Geotek Inc
0.0025 €
(-70.59%)
40k
QP9Atco Mining Inc
0.003 €
(-55.88%)
1.5k
0PV2Moovly Media Inc
0.002 €
(-55.56%)
500
8QPFidus Investment Corp
9.5899 €
(-51.32%)
220
D7GNel ASA
0.2496 €
(-0.79%)
3.89M
RQ0DWave Quantum Inc
7.896 €
(24.07%)
2.16M
FWR0Yumy Candy Company Inc the
0.0352 €
(40.80%)
2.12M
PF8European Lithium Limited
0.0204 €
(-0.97%)
2.07M
DI6Distribuidora Internacional De Alimentacion SA
0.017 €
(1.80%)
1.83M

Discussion

View Full Feed
awesomed007 awesomed007 4 minutes ago
Pps is where it was before the big run up last fall. 🔮🤞
SPZI
northam43 northam43 5 minutes ago
Report #2 December 2024 SPX Cycles

https://investorshub.advfn.com/uimage/uploads/2024/12/23/ivzti2_Completed_Cycles.PNG
ReasearchThis ReasearchThis 5 minutes ago
Did investors hub just hire an admin from.Yahoo.Finance?
And then there are the threats!
Post Date: 12/13/2024 06:37:43 AM
Board: Exxe Group Inc
Reason: Off-Topic (what could possibly be more on topic)

Removed Message (when did questions become off topic?)
AXXA
vein vein 5 minutes ago
Thanks tyrus! Are you  current shareholder?? 
CKPT
ds22 ds22 8 minutes ago
HHSE — “ The awareness campaign for the book has an impressive pedigree as well. Major promotional campaigns have been structured with Elon Musk’s “X” platform and Trump Media’s Truth Social - both designed to drive awareness and pre-sale link traffic to over 200-million social media users. Addition
HHSE
crowin crowin 8 minutes ago
My friend in the share printing press maintenance area was told that the share printing will continue thru 2025

the share printing volume will decrease with a Reverse Stock split coming soon due to current High AS count !

this way they can uplist to NASDAQ
RDAR
123tom 123tom 8 minutes ago
... to continue a little... the large chart picture, shows a 'bottom' zone , let's say 3 dollars. You can analyze from 2 dollars as well, but what I want to show is the picture of major Bottom (reverse head) and then, the series of shoulder zones, as support shoulders, and it looks simple enough t
Zorax Zorax 8 minutes ago
Dang, he shoulda done all that in texas then.
Top Penny Top Penny 8 minutes ago
Something amazing is gonna happen here!
MONI
shotsky shotsky 9 minutes ago
How to KEEP bashers!! Respond to them!
Basher posts are like cheese in a mousetrap, and you are the mouse. They smile with glee for every response they get, and anyone that responds to THOSE posts.
If everyone put them on ignore, they would move on. Learn to use your ignore buttons an
SPZI
Jasbg Jasbg 9 minutes ago
Talk about a disaster's investment AMRN will 'for now' be hard to beat !

Besides that - a good Christmas to everyone 🙂

As "valuation" of AMRN is right now - we are basically in an 'all win situation' - so lets see what 2025 will bring. Where we are cant contin
AMRN
Reac Reac 9 minutes ago
Just saying if the geomagnetic technology got financed with $Millions that would be very huge.
MILLIONS
Huggy Bear Huggy Bear 10 minutes ago
What you consider tip top due diligence I consider mark bait.

How many billions of shares have been diluted into the new circus show?

Is it approaching 19 billion now?

Check A. For Yes:

Check B. For No:
HMBL
I-Glow I-Glow 10 minutes ago
I was looking at the GVSI Twitter feed and this is pretty funny. Anyone that believes in Sharp deserves to lose their investment.

@GeorgeASharp
On February 6, 2024, $GVSI announced that it had enter into a non-binding Term Sheet for the acquisition of a privately owned Blockch
GVSI
Hi_Lo Hi_Lo 10 minutes ago
38m bidding. Biggest bid in a long time🚀

LOL!!!

A whopping $3800 that someone just lost in this scam.

Desperate pumping.
BCAP
TMaga TMaga 11 minutes ago
The average time for a medical device to go through an FDA clinical trial can vary significantly depending on the device's risk level, but generally takes several years with the process including preclinical research, clinical trials, submission of data to the FDA, and review by the agency before ma
ADHC
Preciouslife1 Preciouslife1 11 minutes ago
http://archive.fast-edgar.com/20241223/AP2XE22CZC2232Z22223224ZD5WPZJ92B262/
CDMO
12x 12x 12 minutes ago
Like one study showing benefit in activities of daily living but not cognition and the other showing benefit in cognition but not ADL's? They were consistent in percent dropouts due to tolerability.

Wasn't the ADL miss in the Phase 2b/3 trial primarily due to the inclusion of mild-onl
AVXL
Lime Time Lime Time 12 minutes ago
I wonder if they made a mistake and filed a FS instead of a RS. This is a very odd scenario here. It's not impossible, I mean, if the company is doing good.
MVCO
FACT-MASTER FACT-MASTER 13 minutes ago
TCRX: TScan Therapeutics Refinances Existing Convertible Debt Facility with Term Loan for up to $52.5 Million from Silicon Valley Bank

TScan Therapeutics, Inc.
New non-dilutive structure replaces existing convertible facility maturing in 2026, and extends loan maturity to 2029
FCNCA TCRX
DiscoverGold DiscoverGold 13 minutes ago
NVDA Top Bearish Flow – Close
By: Peter DiCarlo | December 23, 2024

• Top Bearish Flow – Close

TSLA – $-42.78M
CVX – $-17.33M
PFE – $-10.58M
NVO – $-10.11M
BABA – $-9.77M

pbs.twimg.com/media/Gfg0BP0XgAAr-YM
CVX NVDA NVO
barnyarddog barnyarddog 13 minutes ago
Did You Buy the Dip? Yes I bought the Dip.
GCTS
Huggy Bear Huggy Bear 13 minutes ago
No comment. The public can decide for themselves.
HMBL
dstock07734 dstock07734 14 minutes ago
That's laughable.

Have a great week!
NWBO